ArticleInternational journal of endocrinology2022

KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway.

Wenjing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.